StratCare: Using AI to guide depression treatment choices
Official title: StratCare Trial 2: Evaluating the Clinical and Cost-effectiveness of AI-driven Stratified Care for Depression
Run by Rotherham Doncaster and South Humber NHS Foundation Trust · NCT06567340 · Data updated 2026-11-12
Aims to see if an AI tool can help therapists choose the most effective start of care for adults with depression who seek talking-therapy treatment.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 1252 (estimated) |
| Sponsor | Rotherham Doncaster and South Humber NHS Foundation Trust Government |
| Locations | 10 sites (Darlington, Durham and 9 other locations) |
| Status | Recruiting |
| Started | June 27, 2025 |
| Main results expected | September 30, 2026 |
| Study ends | March 31, 2027 |
| Registry record updated | July 28, 2026 |
| Trial ID | NCT06567340 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults 18 and older seeking Talking Therapies for depression with PHQ-9 scores of 10 or higher and who consent to share de-identified data.
✕Probably not a fit
Patients who do not respond to standard treatments within usual care or whose care pathway is not guided by AI may not experience additional benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This pragmatic, multi-site study tests whether StratCare, an AI-guided decision aid, can improve clinical outcomes and reduce costs for adults with depression by recommending starting with brief or more intensive therapy. It uses a cluster randomized design where Talking Therapies teams are assigned to use StratCare or continue usual care, with patients followed through their chosen treatment path. The trial includes an internal pilot and predefined stop/go criteria to decide progression to a full-scale study, and will recruit about 1,252 participants from NHS services across England. Outcomes will consider symptom change, service utilization, and potential cost implications. Participation requires consent to share de-identified data and treatment within eligible Talking Therapies services.
Why it matters
Potential benefit: If successful, StratCare could help tailor initial treatment to individuals, potentially improving recovery rates and reducing unnecessary therapy use.
How similar studies have gone: Past studies in AI-assisted treatment selection for mental health have shown potential, but this design remains relatively novel in routine NHS Talking Therapies settings.
Who can join: the full rules
Show full inclusion / exclusion criteria
In addition to the criteria, participants must be under the treatment of a participating Talking Therapies service. Inclusion criteria: * 18 years of age or older. * Patients who consent to share their de-identified clinical records for research purposes. * Patients assessed as eligible for psychological care in Talking Therapies based on clinical guidelines. * Patients with case-level depression symptoms (PHQ-9 ≥ 10). Exclusion Criteria: • Those who are ineligible for treatment in Talking Therapies services according to standard treatment guidelines.
Where it's running
-
Tees, Esk and Wear Valleys NHS Foundation Trust
Darlington, Durham, United Kingdom Recruiting -
Lancashire and South Cumbria NHS Foundation Trust
Preston, Lancashire, United Kingdom Recruiting -
West London NHS Trust
Southall, London, United Kingdom Recruiting -
Vita Health Group
Nottingham, Nottinghamshire, United Kingdom Recruiting -
Somerset NHS Foundation Trust
Taunton, Somerset, United Kingdom Recruiting -
Rotherham Doncaster and South Humber NHS Foundation Trust
Doncaster, South Yorkshire, United Kingdom Recruiting
Show 4 more locations
-
Surrey and Borders Partnership NHS Foundation Trust
Leatherhead, Surrey, United Kingdom Recruiting -
Cheshire and Wirral Partnership NHS Foundation Trust
Chester, United Kingdom Recruiting -
Homerton Healthcare NHS Foundation Trust
London, United Kingdom Recruiting -
Central and Nort h West London NHS Foundation Trust
London, United Kingdom Recruiting
Study contacts
- Principal investigator: Jaime Delgadillo, Prof — University of Sheffield
- Study coordinator: Jonathan Woodward
- Email: jonathan.woodward@sheffield.ac.uk
- Phone: 0114 2222966
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Smartphone-supported single-session psychotherapy for postpartum depression
A single online therapy session plus four weeks of app-based support is being tested to see if it reduces depressive symptoms in postpartum women compared with a waitlist.
-
Mindful Smartphone Use: A Mindfulness-Based Program for Teens with Sleep and Mood Challenges
This study tests Mindwire, a mindfulness-based program, to see if it helps teens with problematic phone use who also have depression or anxiety.
-
Tele-based wellbeing centres for women's mental health in Bangladesh
A randomized trial tests whether tele-counselling for depression and anxiety in Bangladeshi women is as effective as in-person counselling.
-
Remote monitoring for adults with depression using ThIA Suivi
This study tests whether adding the ThIA Suivi remote monitoring tool to usual psychiatric care helps adults with depression feel more improved after 3 months compared with standard care alone.
-
HBOT to see if it helps cognition and well‑being in first responders with prior brain injury
This study tests whether 40 hyperbaric oxygen therapy sessions can improve thinking skills and post-concussion symptoms in current or former first responders with a history of brain injury.
-
Focused ultrasound for mood and anxiety disorders
This study tests whether repeated low-intensity focused ultrasound using the ATTN201 device can help people with subsyndromal to moderate depression, anxiety, or OCD.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.